Lisata Therapeutics CMO details pancreatic cancer research collaboration with Haystack Oncology - ICYMI

Can you tell us more about Haystack Oncology and about the collaboration itself? What are some of the challenges in the development of anti-cancer therapies for tumors like pancreatic But why we're doing this? To further assess the dose and dose regimen of certepetide. We've designed a trial called Fortified. The trial is evaluating a different patient population, specifically patients with metastatic pancreatic cancer who have progressed on their first-line treatment of FOLFIRINOX. The trial has three coho ...